Here's the live share price of Vanta Bioscience along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Vanta Bioscience has declined 30.57% CAGR. Over the past year, the corresponding return has been -51.87%.
Vanta Bioscience’s current P/E of -1.33x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Vanta Bioscience | 3.48 | -18.04 | -12.66 | -24.92 | -51.87 | -33.44 | -30.57 |
| Sun Pharma Advanced Research Company | -6.45 | 0.91 | -7.65 | -18.48 | -42.39 | -15.11 | -6.65 |
| Suven Life Sciences | 1.60 | -5.11 | -25.13 | -31.07 | 18.92 | 39.07 | 15.09 |
| Vimta Labs | 0.26 | -4.79 | -22.83 | 23.51 | 29.12 | 41.55 | 45.81 |
| Choksi Laboratories | 10.51 | -14.91 | -37.67 | -25.17 | 94.31 | 52.66 | 66.15 |
Over the last one year, Vanta Bioscience has declined 51.87% compared to peers like Sun Pharma Advanced Research Company (-42.39%), Suven Life Sciences (18.92%), Vimta Labs (29.12%). From a 5 year perspective, Vanta Bioscience has underperformed peers relative to Sun Pharma Advanced Research Company (-6.65%) and Suven Life Sciences (15.09%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 20.23 | 20.62 |
| 10 | 21.87 | 21.68 |
| 20 | 23.55 | 22.92 |
| 50 | 24.22 | 24.23 |
| 100 | 24.4 | 26.38 |
| 200 | 32.03 | 33.12 |
In the latest quarter, Vanta Bioscience remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 27.19% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Nov 15, 2025, 12:54 AM IST | Vanta Bioscience - Financial Results For The Half Year Ended September 30, 2025 |
| Nov 15, 2025, 12:48 AM IST | Vanta Bioscience - Board Meeting Outcome for Outcome Of The Board Meeting Held On November 14, 2025 |
| Nov 08, 2025, 9:44 PM IST | Vanta Bioscience - Board Meeting Intimation for Board Meeting To Be Held On 14.11.2025 |
| Nov 02, 2025, 12:41 AM IST | Vanta Bioscience - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer |
| Nov 01, 2025, 10:55 PM IST | Vanta Bioscience - Reg. 34 (1) Annual Report. |
Vanta Bioscience Ltd. is a Public Limited Listed company incorporated on 29/04/2016 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L74999TG2016PLC109280 and registration number is 109280. Currently Company is involved in the business activities of Scientific research and development. Company's Total Operating Revenue is Rs. 8.56 Cr. and Equity Capital is Rs. 6.31 Cr. for the Year ended 31/03/2024.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Vanta Bioscience is ₹20.49 as on Dec 12, 2025.
The Vanta Bioscience is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Vanta Bioscience is ₹14.57 Cr as on Dec 12, 2025.
Today’s highest and lowest price of Vanta Bioscience are ₹20.49 and ₹20.45.
The 52-week high/low is the highest and lowest price at which Vanta Bioscience stock has traded in the past 52-week or nearly a year. The 52-week high of Vanta Bioscience is ₹44.49 and 52-week low of Vanta Bioscience is ₹19.08 as on Dec 12, 2025.
The Vanta Bioscience has shown returns of 3.48% over the past day, -18.04% for the past month, -12.66% over 3 months, -51.87% over 1 year, -33.44% across 3 years, and -30.57% over 5 years.
P/E ratio of and PB ratio of Vanta Bioscience are -1.33 and 1.05 on Dec 12, 2025. While the company gives a dividend yield of 0.00 per annum.